InvestorsHub Logo

TOB

01/18/13 2:31 PM

#21497 RE: eddiebali #21490

Your welcome.

In my Due Diligence, I give much greater weight to existing links to papers published by Dr. Menon in peer reviewed journals than I do to a 4 year old discredited 'article' from a community newspaper that has since been removed as it was filled with inaccuracies to the point of defamation.

In the world of science, being published in peer reviewed publications and having one's novel cancer drug Kevetrin being in clinical trials at the Harvard Cancer Centers and the highly prestigious University of Bologna has far more weight in determining the reputation of a scientist than a discredited hit piece by a second rate hack writing for an unknown community journal, India New England.India New England is just a community rag, and hardly the New York Times.

That India New England deleted the hit piece demonstrates it was false and misleading. It has been debunked repeatedly over the last four years.

Alternatively, all of Dr. Menon's peer reviewed papers remain in publication and have been cited dozens of times.